Has Jamie Carden-Smith received payments from drug or device companies?

Yes. Drug and device makers reported $3,717 in general payments to Jamie Carden-Smith across 161 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jamie Carden-Smith did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jamie Carden-Smith come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jamie Carden-Smith

Family · Murfreesboro, TNNPI 1386127264

Payments from drug & device makers

$3,717in general payments, 2019–2025

Across 161 payments — averaging $23.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nevro Corp.$673
AbbVie$584
Boston Scientific$475
Abbott$299
Amgen$233
Biohaven Pharmaceutical Holding Company Ltd.$220
plus $1K from 18 others

What the payments were for

Food & beverage$3,717100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nevro Corp.	26	$673
AbbVie(2 entities)	22	$584
Boston Scientific	32	$475
Abbott	14	$299
Amgen	4	$233
Biohaven Pharmaceutical Holding Company Ltd.	13	$220
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	11	$188
Lilly USA, LLC	6	$181
Novo Nordisk	7	$174
Otsuka America Pharmaceutical, Inc.	2	$149
Neurelis, Inc.	1	$81
Medtronic	2	$66
Lundbeck LLC	2	$47
Biohaven Pharmaceuticals, Inc.	2	$44
Redhill Biopharma Inc.	2	$42
Pfizer	2	$41
GRT US Holding, Inc.	2	$39
Virtus Pharmaceuticals LLC	2	$36
USWM, LLC	2	$36
Hikma Pharmaceuticals USA	2	$34
Collegium Pharmaceutical, Inc.	2	$30
Almatica Pharma LLC	1	$18
Teva Pharmaceuticals USA, Inc.	1	$15
Arbor Pharmaceuticals, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,717 in reported general payments places this provider in the 85th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	84	$78,151
EliquisApixaban	48	$40,140
FarxigaDapagliflozin Propanediol	15	$16,278
JardianceEmpagliflozin	19	$12,401
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	19	$11,974
Advair HfaFluticasone Propion/Salmeterol	12	$3,712
SynthroidLevothyroxine Sodium	32	$2,739
Pravastatin Sodium	123	$1,770
Atorvastatin Calcium	127	$1,566
Telmisartan	30	$1,329
Gabapentin	66	$1,260
Irbesartan	56	$1,099
Metoprolol Succinate	83	$1,072
Pantoprazole Sodium	97	$1,005
Losartan Potassium	63	$952

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskOzempic	$174	$78,15184 claims
PfizerEliquis	$41	$40,14048 claims
AbbVieSynthroid	$584	$2,73932 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,706 family providers in Tennessee.

Other family in Murfreesboro

Cynthia MillerMurfreesboro$384K
Melanie McGheeMurfreesboro$48K
Stacy BrownMt Juliet$719K
Dana WebberKnoxville$499K
Brandy BiedermanHixson$448K
Tamera ThoenerNashville$254K
April SwonerHermitage$246K
Jennifer WilliamsNashville$213K
Chantil JeffreysGermantown$195K
Laura PorchCordova$148K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →